Full Text View
Tabular View
No Study Results Posted
Related Studies
Rifaximin for the Treatment of Irritable Bowel Syndrome
This study has been completed.
Study NCT00259155   Information provided by Cedars-Sinai Medical Center
First Received: November 25, 2005   Last Updated: March 17, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Irritable Bowel Syndrome
More general conditions related to this trial
Colonic Diseases
Colonic Diseases, Functional
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Interventions listed in this trial
Rifaximin
More general drug interventions related to this trial
Anti-Infective Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Cedars-Sinai Medical Center
University of Chicago
Salix Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services